JENNIFER DOUGLASS: Open Payments
NPI 1922512458 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 96 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,357 · 2025 $2,291
Food & beverage: $2,240Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $554 |
| Janssen Biotech, Inc. | 15 | $474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $452 |
| PFIZER INC. | 5 | $123 |
| Madrigal Pharmaceuticals | 4 | $110 |
| Phathom Pharmaceuticals, Inc. | 7 | $109 |
| QOL Medical, LLC | 4 | $102 |
| Galderma Laboratories, L.P. | 1 | $91 |
| VIVUS LLC | 3 | $60 |
| Lilly USA, LLC | 2 | $57 |
Products named: TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, LINZESS, REZDIFFRA, VOQUEZNA, Sucraid.
Industry payments across IL — which companies pay providers there.
